Researchers assessed the prevalence and characteristics of musculoskeletal manifestations of childhood cancers and identified the factors that differentiated them from juvenile idiopathic arthritis.
Study authors assessed malignancy risk among patients with rheumatoid arthritis receiving combination therapy with Janus kinase inhibitors and methotrexate vs MTX alone.
A study shows 7.8% of patients with psoriasis who were treated with methotrexate developed nonmelanoma skin cancer.
The safety and efficacy of immune checkpoint inhibition in patients with advanced melanoma with and without autoimmune disease was assessed.
An overview for rheumatologists on the management of cancer risk in patients with rheumatoid arthritis.
Electroacupuncture and auricular acupuncture are more effective than usual care at reducing chronic musculoskeletal pain in cancer survivors.
This study compared survival outcomes in patients with lung cancer with and without an existing autoimmune disorder.
In patients with sarcoidosis, cancer was found to develop earlier in men vs women.
Experts highlight the need for cancer screening strategies in patients with rheumatic diseases.
The FDA has approved Crysvita for the treatment of fibroblast growth factor 23 (FGF23)-related hypophosphatemia in tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized in patients aged ≥2 years.
